Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aliskiren in severe hypertension
NCT00299806Phase 3Completed
- Sponsor
- Novartis
- Start
- Apr 2006
- Primary completion
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of aliskiren in hypertension (HTN), sponsored by Novartis. Started Apr 2006; status: completed.
02
Drugs
aliskiren
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00299806.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00299806.